Clinical application of percutaneous radiofrequency ablation used in treatment of advanced lung cancer patients
Wang Hong-bin(Department of Cardiac Surgery, First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054, China)
Objective: To discuss the efficacy and safety of advanced lung cancer patients treated with radiofrequency ablation (RFA). Methods: Twenty-six advanced lung cancer patients were treated with RFA in local anaesthesia. 20 of them punctured induced under C-arm X-ray; 5 under CT scan, 1 through VATS. RFA temperature from 58℃ to 90℃. Procedure time from 16 minutes to 286 minutes. Results: Twenty-nine RFA were done in 26 patients, 3 of them done twice. 12 patients appeared pain during RFA, 8 of them with cough and hemoptysis separately. After RFA, 6 of them presented with pulmonary edema. Pneumothorax in 3 patients, pulmonary hemorrhage in one. No patients died in the hospital. Conclusion: Percutaneous radiofrequency ablation was safe to treat advanced lung cancer. Its long term result need to be studied further.